26, 2016 /PRNewswire/ — Frontier Pharma: Chronic, Acute and Neuropathic Pain – GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes Summary Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain as a disease, rather than just as a symptom of a primary cause. click here to investigateIn the US, pain affects more people than cancer, diabetes and heart disease combined, with an estimated 100 million people having experienced at least one chronic pain episode in the last 12 months, at an annual cost of around $600 billion in medical treatment and lost productivity. The pain therapeutics market has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established product categories, active pharmaceutical ingredients and concomitant mechanisms of action. Moderate-to-severe pain has been and continues to be dominated by opioids, which are increasingly being reformulated to offer abuse-resistance, whereas mild pain is effectively treated with non-steroidal anti-inflammatory drugs (NSAID). However, significant unmet needs remain, as chronic pain subtypes – and particularly neuropathic pain – do not respond well to existing therapies, which do not align to the underlying molecular pathophysiological profile of pain. However, strong unmet needs remain in core therapy types such as NSAIDs, which are associated with often severe gastrointestinal adverse events (AE), and opioids, which have a range of AEs associated with them – in addition to the potential for abuse, which has not been fully alleviated by the development of abuse-deterrent formulations. The exceptionally large active pain pipeline, second only to breast cancer in terms of size, consists of 810 products across all stages of development, indicating that a great deal of resources are being invested into R&D, with the aim of ultimately overcoming the limitations of existing therapies. Moreover, GBI Research’s analyses identified 129 first-in-class programs in active development, constituting 20% of the pipeline for which there is a disclosed molecular target, and acting on 80 distinct first-in-class molecular targets. Although there is significant differentiation in the scientific rationale and clinical prospects across these first-in-class products, the majority of first-in-class targets demonstrate significant preclinical evidence, and alignment to molecular pathophysiological changes. Scope – Analysis of innovation in the pain markets (including both nociceptive and neuropathic pain, of both a chronic and acute nature), in the context of the overall pipeline and current market landscape.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/frontier-pharma-chronic-acute-neuropathic-005700175.html
Wear comfortable and supportive shoes with insoles that fully support the arch. During the gait cycle the foot can probate in many ways based on rear foot and forefoot function. click to investigateThis yields the arch measurement. Medically Reviewed by a Doctor on 7/28/2015 To see all our products – Click Here Foot supports are basically the same as arch supports but foot supports are specifically a one piece, full length insole that incorporates an arch support into its design. Plantar fasciitis is the name that describes inflammation of the fibrous band of tissue that connects the heel to the toes. However, when the same subjects performed the exercise while wearing arch supporting orthotics and shoes, the tibialis posterior was selectively activated. Be sure to measure both feet, then fit the larger foot. It is important to treat the condition promptly before it worsens. Foot problems that can affect people with diabetes include: nerve damage peripheral neuropathy, which can cause numbness and burning, stabbing or shooting pains in your feet poor circulation ischaemia, which can cause your feet to become painful, cold, red and swollen skin ulcers – painful sores that take a very long time to heal skin infections – ulcers that become red and swollen, and may produce a foul-smelling odour and green discharge Contact your GP or diabetes care team immediately if you have diabetes and think you have developed a problem with one or both of your feet. It features a patterned flowery base with a matching orange sle…
You may also be interested to read
- click this link here now